Skip to main content
SpringerLink
Log in

Docetaxel-loaded D-α-tocopheryl polyethylene glycol-1000 succinate liposomes improve lung cancer chemotherapy and reverse multidrug resistance

  • Original Article
  • Published:
Drug Delivery and Translational Research Aims and scope Submit manuscript

Abstract

In this study, D-alpha-tocopheryl polyethylene glycol-1000 succinate (TPGS)–coated docetaxel-loaded liposomes were developed to reverse multidrug resistance (MDR) and enhance lung cancer therapy. Evaluations were performed using human lung cancer A549 and resistant A549/DDP cells. The reversal multidrug resistant effect was assessed by P-gp inhibition assay, cytotoxicity, cellular uptake, and apoptosis assay. The tumor xenograft model was built by subcutaneous injection of A549/DDP cells in the right dorsal area of nude mice. The tumor volumes and body weights were measured every other day. The TPGS-coated liposomes showed a concentration- and time-dependent cytotoxicity and significantly enhanced the cytotoxicity of docetaxel in A549/DDP cells. Confocal laser scanning images indicated that higher concentrations of coumarin-6 were successfully delivered into the cytoplasm, and the TPGS-coated liposomes enhanced intracellular drug accumulation by inhibiting overexpressed P-glycoprotein. The TPGS-coated liposomes were shown to induce apoptosis. Furthermore, in vivo anti-tumor studies revealed that TPGS-coated docetaxel-loaded liposomes had outstanding anti-tumor efficacy in an A549/DDP xenograft model. The TPGS-coated liposomes, compared with PEG-coated liposomes, showed significant advantages in vitro and in vivo. The TPGS-coated liposomes were able to reverse MDR and enhance lung cancer therapy.

.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Assanhou AG, Li W, Zhang L, Xue L, Kong L, Sun H, et al. Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment. Biomaterials. 2015;73:284–95.

    Article  CAS  Google Scholar 

  2. Bajelan E, Haeri A, Vali AM, Ostad SN, Dadashzadeh S. Co-delivery of doxorubicin and PSC 833 (Valspodar) by stealth nanoliposomes for efficient overcoming of multidrug resistance. J Pharm Pharm Sci. 2012;15(4):568–82.

    Article  CAS  Google Scholar 

  3. Kato Y, Okuma Y, Watanabe K, Yomota M, Kawai S, Hosomi Y, et al. A single-arm phase II trial of weekly nanoparticle albumin-bound paclitaxel (nab-paclitaxel) monotherapy after standard of chemotherapy for previously treated advanced non-small cell lung cancer. Cancer Chemother Pharmacol. 2019;84(2):351–8.

    Article  CAS  Google Scholar 

  4. Chang M, Lu S, Zhang F, Zuo T, Guan Y, Wei T, et al. RGD-modified pH-sensitive liposomes for docetaxel tumor targeting. Colloids Surf B Biointerfaces. 2015;129:175–82.

    Article  CAS  Google Scholar 

  5. Cohen K, Emmanuel R, Kisin-Finfer E, Doron S, Dan P. Modulation of drug resistance in ovarian adenocarcinoma using chemotherapy entrapped in hyaluronan-grafted nanoparticle clusters. ACS Nano. 2014;8(3):2183–95.

    Article  CAS  Google Scholar 

  6. Dian L-H, Hu Y-J, Lin J-Y, Zhang J-Y, Yan Y, Cui Y-N, et al. Fabrication of paclitaxel hybrid nanomicelles to treatresistant breast cancer via oral administration. Int J Nanomedicine. 2018;13:719–31.

    Article  CAS  Google Scholar 

  7. Füredi A, Szebényi K, Tóth S, Mihály C, Hámori L, Nagy V, et al. Pegylated liposomal formulation of doxorubicin overcomes drug resistance in a genetically engineered mouse model of breast cancer. J Control Release. 2017;261:287–96.

    Article  Google Scholar 

  8. Gao W, Ye G, Duan X, Yang X, Yang VC. Transferrin receptor-targeted pH-sensitive micellar system for diminution of drug resistance and targetable delivery in multidrug-resistant breast cancer. Int J Nanomedicine. 2017;12:1047–64.

    Article  CAS  Google Scholar 

  9. Guan G, Sun J, Sun F, Lou B, Zhang D, Mashayekhi V, et al. Hypoxia-induced tumor cell resistance is overcome by synergistic GAPDH-siRNA and chemotherapy co-delivered by long-circulating and cationic-interior liposomes. Nanoscale. 2017;9:9190–01.

    Article  CAS  Google Scholar 

  10. Hu Q, Li W, Hu X, Hu Q, Shen J, Jin X, et al. Synergistic treatment of ovarian cancer by co-delivery of survivin shRNA and paclitaxel via supramolecular micellar assembly. Biomaterials. 2012;33(27):6580–91.

    Article  CAS  Google Scholar 

  11. Juang V, Lee H-P, Lin AM-Y, Lo Y-L. Cationic PEGylated liposomes incorporating an antimicrobial peptide tilapia hepcidin 2–3: an adjuvant of epirubicin to overcome multidrug resistance in cervical cancer cells. Int J Nanomedicine. 2016;11:6047–64.

    Article  CAS  Google Scholar 

  12. Kievit FM, Wang FY, Fang C, Mok H, Wang K, Silbe JS, et al. Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro. J Control Release. 2011;152(1):76–83.

    Article  CAS  Google Scholar 

  13. Li Y, Li R, Liu Q, Li W, Zhang T, Zou M, et al. One-step self-assembling nanomicelles for pirarubicin delivery to overcome multidrug resistance in breast cancer. Mol Pharm. 2016:3934–44.

  14. Liu B-Y, Wu C, He X-Y, Zhuo R-X, Cheng S-X. Multi-drug loaded vitamin E-TPGS nanoparticles for synergistic drug delivery to overcome drug resistance in tumor treatment. Sci Bull. 2016;61(7):552–60.

    Article  CAS  Google Scholar 

  15. Liu T, Liu X, Xiong H, Xu C, Yao J, Zhu X, et al. Mechanisms of TPGS and its derivatives inhibiting Pglycoprotein efflux pump and application for reversing multidrug resistancein hepatocellular carcinoma. Polym Chem. 2018:1827–39.

  16. Mu L-M, Ju R-J, Liu R, Bu Y-Z, Zhang J-Y, Li X-Q, et al. Dual-functional drug liposomes in treatment of resistant cancers. Adv Drug Deliv Rev. 2017:46–56.

  17. Muthu MS, Kulkarni SA, Xiong J, Feng S-H. Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells. Int J Pharm. 2011;421(2):332–40.

    Article  CAS  Google Scholar 

  18. Niwa T, Kasuya Y, Suzuki Y, Ichikawa K, Yoshida H, Kurimoto A, et al. Novel immunoliposome technology for enhancing the activity of the agonistic antibody against the tumor necrosis factor receptor superfamily. Mol Pharm. 2018;15(9):3729–40.

    Article  CAS  Google Scholar 

  19. Peng Y, Nie J, Cheng W, Liu G, Zhu D, Zhang L, et al. A multifunctional nanoplatform for cancer chemo-photothermal synergistic therapy and overcoming multidrug resistance. Biomater Sci. 2018;6(5):1084–98.

    Article  CAS  Google Scholar 

  20. Ruiz-Moreno C, Velez-Pardo C, Jimenez-Del-Rio M. Vitamin E D-α-tocopheryl polyethylene glycol succinate (TPGS) provokes cell death in human neuroblastoma SK-N-SH cells via a pro-oxidant signaling mechanism. Chem Res Toxicol. 2018;31(9):945–53.

    Article  CAS  Google Scholar 

  21. Ruttala HB, Ramasamy T, Gupta B, Gupta B, Choi HG, Yong CS, et al. Multiple polysaccharide–drug complex-loaded liposomes: a unique strategy in drug loading and cancer targeting. Carbohydr Polym. 2017;173:57–66.

    Article  CAS  Google Scholar 

  22. Shen J, Kim H-C, Wolfram J, Mu C, Zhang W, Liu H, et al. A liposome encapsulated ruthenium polypyridine complex as a theranostic platform for triple-negative breast cancer. Nano Lett. 2017;17:2913–20.

    Article  CAS  Google Scholar 

  23. Shi C, Zhang Z, Shi J, Wang F, Luan Y. Co-delivery of docetaxel and chloroquine via PEO–PPO–PCLTPGS micelles for overcoming multidrug resistance. Int J Pharm. 2015;495(2):932–9.

    Article  CAS  Google Scholar 

  24. Shi C, Zhang Z, Wang F, Luan Y. Docetaxel-loaded PEO–PPO–PCL/TPGS mixed micelles for overcoming multidrug resistance and enhancing antitumor efficacy. J Mater Chem B Mater Biol Med. 2015:4259–71.

  25. Song X, Zhu J, Wen Y. Thermoresponsive supramolecular micellar drug delivery system based on star-linear pseudo-block polymer consisting of b-cyclodextrin-poly(N-isopropylacrylamide) and adamantyl-poly(ethylene glycol). J Colloid Interface Sci. 2017;490:372–9.

    Article  CAS  Google Scholar 

  26. Song J, Huang H, Xia Z, Wei Y, Yao N, Zhang L, et al. TPGS/phospholipids mixed micelles for delivery of icariside II to multidrug-resistant breast cancer. Integr Cancer Ther. 2016;15(3):390–9.

    Article  CAS  Google Scholar 

  27. Tan S, Zou C, Zhang W, Lin M, Gao X, Tang Q, et al. Recent developments in d-alpha-tocopheryl polyethylene glycol-succinate-based nanomedicine for cancer therapy. Drug Deliv. 2017;24(1):1831–42.

    Article  CAS  Google Scholar 

  28. Tang J, Zhang L, Gao H, Liu Y, Zhang Q, Ran R, et al. Co-delivery of doxorubicin and P-gp inhibitor by a reduction-sensitive liposome to overcome multidrug resistance, enhance anti-tumor efficiency and reduce toxicity. Drug Deliv. 2015:1–14.

  29. Chen G, Sheng L, Du X. Efficacy and safety of liposome-paclitaxel and carboplatin based concurrent chemoradiotherapy for locally advanced lung squamous cell carcinoma. Cancer Chemother Pharmacol. 2018.

  30. Tang S, Yin Q, Zhang Z, Gu W, Chen L, Yu H, et al. Co-delivery of doxorubicin and RNA using pH-sensitive poly (b-aminoester) nanoparticles for reversal of multidrug resistance of breast cancer. Biomaterials. 2014;35(27):6047–59.

    Article  CAS  Google Scholar 

  31. Vahed SZ, Salehi R, Davaran S, Simin S. Liposome-based drug co-delivery systems in cancer cells. Mater Sci Eng C. 2017;71:1327–41.

    Article  Google Scholar 

  32. Chen L, Han X, Hu Z, Chen L. The PVT1/miR-216b/Beclin-1 regulates cisplatin sensitivity of NSCLC cells via modulating autophagy and apoptosis. Cancer Chemother Pharmacol. 2019;83(5):921–31.

    Article  CAS  Google Scholar 

  33. Li N, Tingting F, Fei W, Han T, Xiangshuai G, Hou Y, et al. Vitamin E D-alpha-tocopheryl polyethylene glycol 1000 succinate-conjugated liposomal docetaxel reverses multidrug resistance in breast cancer cells. J Pharm Pharmacol. 2019;71(8):1243–54.

    Article  CAS  Google Scholar 

  34. Wang Y, Feng L, Yang X, Wang F, Lu W. Folic acid-conjugated liposomal vincristine for multidrug resistant cancer therapy. Asian J Pharm Sci. 2013;8(2):118–27.

    Article  Google Scholar 

  35. Wu C, Gong M-Q, Liu B-Y, Zhuo R-X, Cheng S-X. Co-delivery of multiple drug resistance inhibitors by polymer/inorganic hybrid nanoparticles to effectively reverse cancer drug resistance. Colloids Surf B Biointerfaces. 2016;19:250–9.

    Google Scholar 

  36. Xia Y, Wang X, Cheng H, Fang M, Ning P, Zhou Y, et al. A polycation coated liposome as efficient siRNA carrier to overcome multidrug resistance. Colloids Surf B Biointerfaces. 2017;159:427–36.

    Article  CAS  Google Scholar 

  37. Yang C, Wu T, Qi Y, Zhang Z. Recent advances in the application of vitamin E TPGS for drug delivery. Theranostics. 2018;8(2):464–85.

    Article  CAS  Google Scholar 

  38. Ranson MR, Cheeseman S, White S, Margison J. Caelyx (stealth liposomal doxorubicin) in the treatment of advanced breast cancer. Crit Rev Oncol Hematol. 2001;37(2):115–20.

    Article  CAS  Google Scholar 

  39. Stebbing J, Gaya A. Pegylated liposomal doxorubicin (Caelyx?) in recurrent ovarian cancer. Cancer Treat Rev. 2002;28:121–5.

    Article  CAS  Google Scholar 

  40. Huang C. Studies on phosphatidylcholine vesicles, formation and physical characteristics. Biochemistry. 1969;8:344–52.

    Article  CAS  Google Scholar 

  41. Samad A, Sultana Y, Aqil M. Liposomal drug delivery systems: an update review. Curr Drug Deliv. 2007;4:297–305.

    Article  CAS  Google Scholar 

  42. Qu M-H, Zeng R-F, Fang S, Dai Q-S, Li H-P, Long J-T. Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer. Int J Pharm. 2014;474:112–22.

    Article  CAS  Google Scholar 

  43. Yu L, Dong A, Guo R, Yang M, Deng L, Zhang J. DOX/ICG coencapsulated liposome-coated thermosensitive nanogels for NIR-triggered simultaneous drug release and photothermal effect. ACS Biomater Sci Eng. 2018:2424–34.

  44. Zhou J, Dong F, Cui F, Xu R, Tang X. The role of circulating tumor cells in evaluation of prognosis and treatment response in advanced non-small-cell lung cancer. Cancer Chemother Pharmacol. 2017:825–33.

  45. Zhang X, Guo S, Fan R, Yu M, Li F, Zhu C, et al. Dual-functional liposome for tumor targeting and overcoming multidrug resistance in hepatocellular carcinoma cells. Biomaterials. 2012;33(29):7103–14.

    Article  CAS  Google Scholar 

  46. Zhang X, He F, He K, Zhang J, Xu M, Long P, et al. CD44-targeted facile enzymatic activatable chitosan nanoparticles for efficient antitumor therapy and reversal of multidrug resistance. Biomacromolecules. 2018:883–95.

  47. Zhao P, Li L, Zhou S, Qiu L, Qian Z, Liu X, et al. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance. Mater Sci Eng C. 2018;84:108–17.

    Article  CAS  Google Scholar 

  48. Zhao Y-Z, Dai D-D, Lu C-T, Chen L-J, Lin M, Shen X-T, et al. Epirubicin loaded with propylene glycol liposomes significantly overcomes multidrug resistance in breast cancer. Cancer Lett. 2013;30(1):74–83.

    Article  Google Scholar 

  49. Lian D, Chen Y, Xu G, Zeng X, Li Z, Li Z, et al. Delivery of siRNA targeting HIF-1a loaded chitosan modified D-a-tocopheryl polyethylene glycol 1000 succinate-b-poly(3-caprolactone-ran-glycolide) nanoparticles into nasopharyngeal carcinoma cell to improve the therapeutic efficacy of cisplatin. RSC Adv. 2016;6(44):37740–9.

    Article  CAS  Google Scholar 

Download references

Author information

Author notes

  1. Na Li and Yaping Mai contributed equally to this work.

Authors and Affiliations

  1. Department of Pharmaceutics, School of Pharmacy, Ningxia Medical University, No. 1160 Shengli South Street, Yinchuan, 750004, People’s Republic of China

    Na Li, Yaping Mai, Qiang Liu, Guojing Gou & Jianhong Yang

Authors
  1. Na Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yaping Mai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qiang Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Guojing Gou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jianhong Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jianhong Yang.

Ethics declarations

All animal studies were performed in compliance with the guidelines outlined in the Guide for the Care and Use of Laboratory Animals. All animal experiments were reviewed and approved by the Animal Experiment Ethics Committee of Ningxia Medical University.

Conflict of interest

The authors declare that they have no conflicts of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, N., Mai, Y., Liu, Q. et al. Docetaxel-loaded D-α-tocopheryl polyethylene glycol-1000 succinate liposomes improve lung cancer chemotherapy and reverse multidrug resistance. Drug Deliv. and Transl. Res. 11, 131–141 (2021). https://doi.org/10.1007/s13346-020-00720-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13346-020-00720-9

Keywords

Search

Navigation